New Duck Disease
New Duck Disease
New Duck Disease
Riemerella anatipestifer
- a bacterial pathogen that affects ducklings, gosling, turkeys, and other fowl.
Riemerella anatipestifer (formerly Pasteurella anatipestifer) is a highly contagious, widely
distributed bacterial pathogen that primarily affects
young ducklings
less frequently, older developer-aged
rarely, breeder-aged ducks, as well as turkeys and geese.
In typical cases, affected ducklings in the terminal stages of disease lie on their backs,
paddling their legs. Stunting may occur in survivors, with scarring of air sacs and the
pericardium resulting in condemnation at slaughter.
Necrotic dermatitis on the lower back or around the vent may also occur. Fibrinous
exudate in the pericardial cavity and over the surface of the liver is the most
characteristic lesion.
Fibrinous airsacculitis is common, and infection of the CNS can result in fibrinous
meningitis. The spleen and liver may be swollen. Pneumonia may occur.
DIAGNOSIS
Clinical findings, age of disease onset, gross findings, and aerobic culture are definitive
for most field infections.
Brain, heart, liver, spleen, air sac, and lung are preferred organs to harvest samples for
culture testing (listed in order of importance for sampling).
Serotyping is typically performed for vaccine and bacterin selection or epidemiological
studies.
Diagnosis of Riemerella anatipestifer is based on typical CNS signs (if present), lesions,
and isolation and identification of the causative organism (using traditional biochemical
characterization). Other diseases (eg, colibacillosis, salmonellosis, Pasteurella
multocida infection, and chlamydiosis) may produce similar lesions.
Tryptic soy or chocolate agar medium is recommended for isolation, although blood
agar is also used, with incubation at 37°C under 5% carbon dioxide or, less optimally,
in a candle jar.
Recently, matrix-assisted laser desorption ionization time-of-flight mass spectrometry
(MALDI-TOF MS) has been used successfully for identification and is quickly becoming
the preferred diagnostic method for most larger laboratories.
PREVENTION AND CONTROL
Strict biosecurity should be maintained, with regular cleaning and disinfection of
facilities.
Appropriate vaccines or bacterins (guided by serotyping or whole genomic sequencing)
should be administered in naive ducklings and breeder birds on most commercial duck
and goose farms.
All-in/all-out management systems should be used when applicable and down time
should be allotted between flocks.
Careful management practices are important for prevention of Riemerella
anatipestifer infection.
A high level of biosecurity is essential.
Cleaning and disinfection between flocks and separation of flocks on multiple-age farms
are other factors of major importance.
Rigid sanitation and depopulation are necessary for elimination of the disease on
endemically infected farms. Allowing facilities to dry out and be exposed to hot dry air
can reduce pathogen burdens on some facilities.
A bacterin and a live vaccine, both including the three most common serotypes of R
anatipestifer (ie, serotypes 1, 2, and 5), are available for use in ducks and naive
ducklings, respectively.
Autogenous bacterins for other serotypes are available from multiple vaccine makers.
An autogenous oil-emulsion bacterin can be used in turkeys. Breeder ducks can be
vaccinated with a bacterin or live vaccine to provide protection to the ducklings that
may last until duckings are 2–3 weeks old.
Sulfaquinoxaline or a combination of penicillin and streptomycin can be used for
initial treatment; however, antimicrobial susceptibility testing should be performed
because multidrug-resistant strains are becoming more prevalent due to antimicrobial
use and development of antimicrobial gene resistance.
Enrofloxacin is highly effective in preventing death in ducklings when administered in
the drinking water; however, use of quinolones or most other antimicrobials in poultry
operations is not allowed in many countries.